Evidence map›Paper›PMID 39990539›Full record

ArticleMedical journal, Armed Forces India

Designing and cloning of fusion protein CpsA-CpsC-L-ACAN.

Elmira Babakanrad, Taher Mohammadian, Davoud Esmaeili, Payam Behzadi

Abstract read
In one paragraph

Article in Medical journal, Armed Forces India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elmira BabakanradDepartment of Microbiology, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran.
Taher MohammadianDepartment of Microbiology, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran.
Davoud EsmaeiliDepartment of Microbiology & Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Payam BehzadiDepartment of Microbiology, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cervical cancer is the fourth most common cause of cancer and the fourth most common cause of cancer deaths in women. Some reports have shown the effect of Methods: This study aimed to design and produce a fusion of recombinant protein (containing the capsules of Results: The results of Gastro-Oesophageal Reflux 4 (GOR4) analysis showed a little extended strand (30.63%), a random coil with a percentage (50.18%), and an alpha helix with a percentage (19.19%). The recombinant protein was confirmed by SDS-PAGE and western blotting with Anti-his tag. Conclusion: The purpose of peptide fusion design in this article is to help in the development of anti-cervical cancer medicine. Of course, this issue needs to be investigated in animal and human phases. In this article, only bioinformatics investigations and validation of the results in the laboratory have been discussed.

Indexed as

Fusion proteinSDS-PAGE methodWestern blotting method

Identifiers

PMID39990539
PMCPMC11842926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.